Five minutes of straight talk between doctors and problem drinkers could help reduce the toll of alcohol-related injuries, violence and accidents. Doctors have long questioned whether a single, short discussion with patients about their drinking could have significant effects on alcohol-related problems, despite dozens of studies supporting such “brief interventions.” However, a new review should lay those doubts to rest.
Services that help women understand the way that their inherited genetic make-up influences their risk of getting breast cancer ease distress and decrease their levels of cancer worry. There is, however, insufficient evidence to make recommendations about the best way of delivering these services.
A surprising technique to concentrate, manipulate, and separate a wide class of swimming bacteria has been identified through a collaboration between researchers at Argonne National Laboratory, Illinois Institute of technology, University of Arizona at Tucson, and Cambridge University, UK.
The American Association for Cancer Research, together with the Food and Drug Administration and National Cancer Institute, today announces the formation of the AACR-FDA-NCI Cancer Biomarkers Collaborative to facilitate the use of validated biomarkers in clinical trials and ultimately in evidence-based oncology and cancer medicine.
As a birth-control surgery technique grows in popularity, a new review of studies underlines the importance of physician training for no-scalpel vasectomies, a method that is more difficult to learn than conventional surgery.
“ACP strongly believes in the goal of widespread adoption and use of health information technology to improve quality of care,” Michael H. Zaroukian, M.D., Ph.D., F.A.C.P., told the National Committee on Vital and Health Statistics subcommittee on Privacy and Confidentiality today at their hearing on “Consumer Controls for Sensitive Health Records.”
Abbott Diabetes Care announced the launch of its FreeStyle Lite? blood glucose monitoring system for people with diabetes after receiving a 510(k) clearance from the U.S. Food and Drug Administration.
Minnesota’s bill to protect seriously ill patients from arrest for using medical marijuana with a doctor’s recommendation cleared another critical milestone today as the Senate Health and Human Services Budget Division passed S.F. 345 ? the medical marijuana bill ? 6?4.
Merck announced the Company has submitted a supplemental Biologics License Application (sBLA) for GARDASIL? [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the U.S. Food and Drug Administration (FDA) to update the labeling for GARDASIL, the cervical cancer vaccine.
The GlaxoSmithKline cervical cancer candidate vaccine, CERVARIX(R), demonstrated 100 percent efficacy in preventing precancerous lesions due to cancer-causing human papillomavirus types 16 and 18 for up to 5.5 years in an extended follow-up trial, according to data presented at the American Association for Cancer Research.